Category Archives: HYPOGONADISM

Reading Time: < 1 minuteJordan Meyers Jordan Meyers has been a freelance writer, specializing in health, education, business, and parenting topics for more than a decade and a copy editor since 2008. Meyers has written Web and print copy for hundreds of businesses, including many Fortune 500 companies. She holds a Bachelor of Science in biology from the University of Maryland and is studying for a bachelor's degree in psychology. Hypogonadism is a condition that can affect both males and females. It is marked by the failure of the sex glands, called gonads, to perform as they should. While this condition is not fatal … Read more »

Reading Time: 2 minuteshypogonadism,in men, decreased testicular function that results in testosterone deficiency and infertility. Hypogonadism is caused by hypothalamic, pituitary, and testicular diseases. Hypothalamic and pituitary diseases that may cause decreased testicular function include tumours and cysts of the hypothalamus, nonsecreting and prolactin-secreting pituitary tumours, trauma, hemochromatosis (excess iron storage), infections, and nonendocrine disorders, such as chronic illness and malnutrition. The primary testicular disorders that result in hypogonadism in postpubertal men include Klinefelter syndrome and related chromosomal disorders, although these disorders usually manifest at the time of puberty. Other causes of hypogonadism in men include testicular inflammation (orchitis) caused by mumps; exposure … Read more »

Reading Time: < 1 minuteTreato does not review third-party posts for accuracy of any kind, including for medical diagnosis or treatments, or events in general. Treato does not provide medical advice, diagnosis or treatment. Usage of the website does not substitute professional medical advice. The side effects featured here are based on those most frequently appearing in user posts on the Internet. The manufacturer's product labeling should always be consulted for a list of side effects most frequently appearing in patients during clinical studies. Talk to your doctor about which medications may be most appropriate for you. The information reflected here is dependent upon … Read more »

Reading Time: < 1 minuteUnit Project 1 Hypogonadotropic hypogonadism By: Caitlin M Read more here: Unit Project 1 Hypogonadotropic hypogonadism - Video … Read more »

Reading Time: 2 minutesQ. I recently turned 50. Ive been taking Livalo for high cholesterol and have been experiencing symptoms like no sexual desire. In addition, I cant sleep through the night, feel totally exhausted and have missed several days of work. My doctor prescribed AndroGel to treat low testosterone levels. Could Livalo be causing all my problems? A. There is evidence that statin-type cholesterol-lowering drugs reduce testosterone levels (BMC Medicine, Feb. 28, 2013). That means that drugs like pitavastatin (Livalo), atorvastatin (Lipitor) and simvastatin (Zocor) may lower this important hormone, which could have an impact on libido and sexual performance (Journal of … Read more »

Reading Time: 2 minutesIs testosterone therapy more of a benefit or risk for male patients? Its a question once again under the microscope after a 2014 PLOS One study looked at the risk of acute non-fatal myocardial infarction (MI) after men were prescribed a form of testosterone therapy. In lay terms, a myocardial infarction, or MI as it is known, is a heart attack. The study found that men aged 65 and older had twice the risk of having a heart attack after taking a testosterone therapy prescription for 90 days. It also found that the heart attack risk for those participants declined … Read more »

Reading Time: 2 minutesLONDON, March 12, 2015 /PRNewswire/ -- Summary Global Markets Direct's, 'Hypogonadotropic Hypogonadism - Pipeline Review, H1 2015', provides an overview of the Hypogonadotropic Hypogonadism's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hypogonadotropic Hypogonadism, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hypogonadotropic Hypogonadism and special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from … Read more »

Reading Time: < 1 minuteHypogonadism in men living with HIV Description. By: Southeast ATEC More: Hypogonadism in men living with HIV - Video … Read more »

Reading Time: 2 minutesPublished 21 October 2014 Apricus Biosciences has licensed the U.S. development and commercialization rights for a novel selective estrogen receptor modulator ("SERM"), fispemifene, an investigational treatment for urological conditions in men, from Forendo Pharma, a private therapeutics company based in Finland. This license agreement combines Apricus' expertise in men's health with Forendo's established leadership in SERM drug discovery, to advance the development of fispemifene as an investigational treatment for urological conditions in men. Fispemifene is an oral once-daily, new chemical entity SERM, with a unique profile that is ideally suited for use in men. Fispemifene is a tissue-specific SERM designed … Read more »

Reading Time: 2 minutesSolutions for less moustache and Beard growth I am 21, but I dont have enough moustache and beard d in my face, how to grow it up, is there any medicines for it? My friends tease me. I scared of getting married since my moustache and beard not developed. Would it affect my personal life? Normally boys show their growth between the ages of 13 to 16 years. The secondary sexual characters like hair growth, starts from above the upper lip, chin and body. Only the sexual hormones bring these changes. Serum Testosterone is the authority for Masculine features. How … Read more »

Reading Time: 3 minutesPublished 21 October 2014 Apricus Biosciences announced that it has licensed the U.S. development and commercialization rights for a novel selective estrogen receptor modulator ("SERM"), fispemifene, an investigational treatment for urological conditions in men, from Forendo Pharma, a private therapeutics company based in Finland. This license agreement combines Apricus' expertise in men's health with Forendo's established leadership in SERM drug discovery, to advance the development of fispemifene as an investigational treatment for urological conditions in men. Fispemifene is an oral once-daily, new chemical entity SERM, with a unique profile that is ideally suited for use in men. Fispemifene is a … Read more »

Reading Time: < 1 minuteBy Irvin H. Hirsch, MD NOTE: This is the Professional Version. CONSUMERS: Click here for the Consumer Version NOTE: This is the Professional Version. DOCTORS: Click here for the Consumer Version Hypogonadism is defined as testosterone deficiency with associated symptoms or signs, deficiency of spermatozoa production, or both. It may result from a disorder of the testes (primary hypogonadism) or of the hypothalamic-pituitary axis (secondary hypogonadism). Both may be congenital or acquired as the result of aging, disease, drugs, or other factors. Additionally, a number of congenital enzyme deficiencies cause varying degrees of target organ androgen resistance. Diagnosis is confirmed … Read more »

Reading Time: 2 minutesPUBLIC RELEASE DATE: 7-Feb-2014 Contact: Jenni Glenn Gingery jgingery@endocrine.org 301-941-0240 The Endocrine Society Chevy Chase, MDAccording to a statement issued today by the Endocrine Society, the risks and benefits of testosterone therapy for older men with declining levels of the hormone need to be fully evaluated. The statement comes in response to recent studies that have raised concerns about the safety of testosterone therapy in older men with a history of heart disease. Two retrospective analyses and one randomized trial supported by the Veterans Health Care System, and the National Institutes of Health found a higher rate of cardiovascular events … Read more »

Reading Time: 2 minutesDr. Darius Paduch/Weill Cornell Medical College This 3-D model illustrates what happens to ones spine and posture due to osteoporosis. Vertebral bones weaken and the spine develops an abnormal arc as the disease progresses, causing a hunchback-like posture. That biomarker, an enzyme called alkaline phosphatase, can be checked through a test similar to a routine blood draw, making this type of screening preferable to the more expensive and invasive DEXA scan, which measures bone density through a specialized form of X-ray. Alkaline phosphatase is easy to measure, and its a reliable marker of bone turnaround, said Dr. Darius Paduch, associate … Read more »

Reading Time: < 1 minuteMale Hypogonadism Therapeutic Pipeline Industry Review, H2 2014 Read more at http://www.rnrmarketresearch.com/male-hypogonadism-pipeline-review-h2-2014-market-report.html This report provides comprehensive information on ... By: Richard Parker More: Male Hypogonadism Therapeutic Pipeline Industry Review, H2 2014 - Video … Read more »

Reading Time: 2 minutesIn men 45 and older, most cases of hypogonadism or Low-T often go overlooked due to the fact that the symptoms may be more general in nature and slower in onset. Many men simply attribute their symptoms to aging and often dismiss them because they don't think that there is anything that they can do about them. This is largely because the symptoms of hypogonadism are nearly identical to those experienced by men going through andropause (the male menopause): low libido, fatigue, depression, memory loss, difficulty concentrating and irritability. The difference between andropause and hypogonadism is simple. Andropause is a … Read more »

Reading Time: < 1 minuteMale Hypogonadism What is Male Hypogonadism? Male hypogonadism is the inability of the testicles to produce testosterone, sperm or both. Male hypogonadism also is called testosterone deficiency. What are Testicles? Testicles are external genital organs that are part of the male reproductive system. These two oval-shaped organs reside in a pouch of skin that hangs below the abdomen and behind the penis. The skin of pouch that contains the testicles is called the scrotum. In addition to producing the sperm cells that are necessary for reproduction, the testicles secrete the male hormone testosterone. Testosterone plays an important role in the … Read more »

Reading Time: 2 minutesEndo International ( ENDP ) was up 3.3% after the company announced that it has entered into an agreement to acquire the rights to Natesto (testosterone nasal gel) from Trimel BioPharma SRL, a wholly owned subsidiary of Trimel Pharmaceuticals Corp. ( TRLPF ). Endo expects to complete the transaction in early 2015. The FDA has cleared Natesto in May 2014 for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone including primary hypogonadism (congenital or acquired) and hypogonadotropic hypogonadism (congenital or acquired). As per the terms of the agreement, Endo will acquire sole and … Read more »